Cantargia
Cantargia: Novartis Fails to Meet Endpoints in CANOPY-1 (Redeye)
2021-10-26 09:00
Redeye discusses Novartis' top-line results from CANOPY-1. We have a neutral stance on the news as it pertains to Cantargia.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se